Eric R. Olson, Chief Scientific Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 689 shares at $3.50 ($2K) on 2023-07-17, disclosed to the SEC on 2023-07-18.
Scheduled sale ($2k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SYRS | SELL | 2021-03-17 | $34K | — | Filing → |
| SYRS | SELL | 2020-08-19 | $205K | — | Filing → |
| SYRS | SELL | 2020-07-07 | $21K | — | Filing → |